Companion Animal Vaccines Market

Companion Animal Vaccines Market Size

Vaccines for companion animals With approximately USD 3 billion in market size projected to rise at 6.6% CAGR between 2023 and 2032, Growing frequency of zoonotic diseases and high disposable income have driven global market expansion.

To get key market trends

  Download Free Sample

Mostly adopted in industrialized nations like Germany and the United States, pets are kept for company by older people. For example, the American Pet Products Association (APPA) estimates that seventy percent of American households have a pet by 2022. Furthermore, shift from pet owners to pet parents showing pets as a part of the family nowadays shows change. Therefore, increased acceptance of pets speeds up the demand for companion animal vaccines and market expansion.

What are the growth opportunities in this market?

 Download Free Sample

Made to guard animals against bacterial, viral, and fungal diseases brought on by pathogens, companion animal vaccines are biological formulations. Considered as a successful means of disease prevention, companion animal vaccinations help to reduce the disease load in pet animals. These vaccinations limit pathogenic animal to human transfer, enhance pet health, and help animals' welfare and general state.

Covid-19 Impact

Hi there! Thus, believe it or not, this insane COVID-19 epidemic has a good side for our animal pals. Stuck at home, people started wondering what they should do. They owned several animals. Adoption rates at animal shelters surged, and more individuals than ever started owning pets. And here's the crucial pointPeople can transmit COVID-19 to animals; pets are not immune. Actually, we have observed rather a few examples of dogs and cats being sick. What then did that mean? More pet owners said, "Hey, we need to protect our furry pals!" Vaccines then entered the picture. People were spending more money on vaccinations since they wanted to protect their animals from this frightening sickness. This is the reason the market for companion animal vaccinations actually witnessed increase during the epidemic. It was as if "more pets, more concern, more vaccines!" Thus, it's not entirely negative news after all. Our dogs are staying healthy and have better loving homes.

Companion Animal Vaccines Market Trends

The need for pet vaccinations is probably going to explode in the next years as more diseases leap from animals to humans all around. Because they can be contracted by coming into touch with sick animals, these "zoonotic" diseases pose a major hazard to people. From minor to fatal, they can produce a wide spectrum of symptoms. Actually, infections such SARS, avian flu, and rabies—which can be fatal without treatment—have been on rise. Since both humans and animals are affected by these diseases, the rising global case count has generated a great need for precise diagnosis and prevention. And for this reason companion animal vaccinations are important.

Lack of well-developed infrastructure and stringent regulatory scenario for vaccine development may impede the market growth

Lack of well-developed infrastructure and resources for vaccination development as well as low pet healthcare spending in developing nations could impede the market expansion. The OECD Development Co-operation Report 2020, for example, underlined the dearth of certain industrial techniques, clinical infrastructure, and more especially, the financial resources in the developing countries. Furthermore controlling veterinary biologics products including animal vaccinations is the Center for Veterinary Biologics (CVB) of the Animal and Plant Health Inspection Service. For veterinary biologics to be used in the treatment and prevention of animal diseases, this control guarantees their purity, safety, potency, and efficacy.

In line with technical criteria specified in Annex 1, Title II, to Directive 2001/82/EC, as changed by Directive 2009/9/EC, and the European Pharmacopoeia (Ph. Eur.), the European Medicines Agency (EMA) also keeps an eye on the development and commercialization process of companion animal vaccinations. Every commercially sold animal vaccination has to satisfy rigorous technical standards and go through a thorough regulatory approval process. Thus, strict regulatory environment and lack of scientific and financial resources for vaccine research may limit the companion animal vaccines market growth.

Companion Animal Vaccines Market Analysis

Learn more about the key segments shaping this market

 Download Free Sample

When it comes to vaccines for our furry friends, there are different types to choose fromlive attenuated, inactivated, recombinant, and others. In 2022, the live attenuated vaccine stole the show with over 45% of the market. And guess what? This trend is expected to continue. These live attenuated vaccines are like mini warriors against disease. They've been weakened in the lab, so while they still look like the real deal, they're too mellow to cause an infection. But don't let that fool you! They're super effective at teaching your pet's immune system to fight off the real bad guys. Most of the vaccines you see at the vet's office are live attenuated. They're not only great at protecting your pet, but they also last a long time and often just one dose is enough. Plus, they're relatively affordable in developing countries. All these perks make them the go-to choice for pet owners.

Learn more about the key segments shaping this market

 Download Free Sample

When it comes to vaccinating our furry friends, the market for companion animal vaccines focuses on four main typesdogs, cats, horses, and birds. Out of these, dogs have been the clear frontrunners, taking up over half of the market in 2022. And they're not slowing down anytime soon. The reason for this surge in popularity? More and more people are welcoming dogs into their families around the world. Places like the United Kingdom, Poland, and France have a particularly strong affinity for canine companions. This means more pet owners are looking for vaccines to keep their beloved dogs healthy, both core vaccines and those that protect against specific risks. So, with so many homes filled with furry canine friends, the companion animal vaccines market has a bright future ahead, especially in countries where dogs are the most popular companions.

When it comes to giving vaccines to pets, there are three main ways to do itshots, oral vaccines, and sprays. Right now, shots are the most popular option, making up the biggest slice of the pet vaccine market. Shots are given under the skin or into the muscle, and they're the best choice for diseases that require a strong immune response throughout the body. This is because shots help the vaccine spread throughout the body, protecting your pet against the disease. They also tend to cause fewer side effects at the injection site, like swelling or pain. Studies have shown that shots give pets the best immune protection, with fewer side effects. They're also more effective at triggering both short-lived and long-lasting immune responses, which is why vets often recommend them for serious diseases. Because of this, shots are likely to stay the most popular way to vaccinate pets in the future.

When it comes to buying vaccines for your furry friends, you've got a few options. You can head to the vet's office pharmacy, swing by a regular pharmacy, or shop online. Back in 2022, most people were getting their pet vaccines at the vet's pharmacy. And guess what? That's expected to keep growing over the next ten years. That's because vaccines are super important for keeping your pets healthy, and vets are the ones who usually give them. Many vet offices even have their own pharmacies where you can pick up any meds your pet needs. To make things even easier, vaccine companies are teaming up with vet clinics to make sure you can easily get your pet's shots right at the office. That means the future looks bright for getting your furry companions the protection they need.

Looking for region specific data?

 Download Free Sample

The pet vaccine market in North America is booming! In 2022, it was worth a ton of money, and it's expected to keep growing by a hefty 6.8% every year. Why is this market so huge? Well, it's all about our furry friends! More and more people are becoming pet parents, and they're realizing how important it is to keep their furry pals healthy. Plus, the number of diseases that can spread from animals to humans (called zoonotic diseases) is on the rise. In the United States alone, there are over 69 million pet dogs and 45 million pet cats. And guess what? Pet owners are spending more and more on their furry family members' healthcare. So, with more pets and more people spending money on their health, it's no wonder that the pet vaccine market is booming!

Companion Animal Vaccines Market Share

Major market players operating in the companion animal vaccines industry include

• Elanco Animal Health Incorporated
• Merck & Co., Inc
• Boehringer Ingelheim International GmbH
• Zoetis Inc.

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.

Companion Animal Vaccines Industry News

• In June 2021, Zoetis announced a collaboration with Canine Companions for Independence (CCI) to provide vaccines and other healthcare products to service dogs. This strategic engagement helped the company in strengthening its product offerings with respect to canine vaccines among other health products & services. 
• In April 2021, Boehringer Ingelheim announced the launch of Feligen RCPCh, a new vaccine for cats that protects against several infectious diseases, including feline herpesvirus and calicivirus. This product launch helped the firm to bolster its position in the feline vaccine offerings and offered a competitive advantage.

The companion animal vaccines market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments

Click here to Buy Section of this Report

By Vaccine Type

• Live Attenuated
• Inactivated
• Recombinant
• Others

By Animal Type

• Canine
• Feline
• Equine
• Avian

By Route of Administration

• Injection Vaccines
• Oral Vaccines
• Spray Vaccines

By Distribution Channel

• Veterinary Hospital Pharmacies
• Retail Pharmacy
• Online Stores

The above information is provided for the following regions and countries

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Poland
  • Sweden
  • The Netherlands
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Indonesia
  • Philippines
  • Malaysia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Columbia
  • Chile
  • Peru
  • Rest of Latin America
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Iran
  • Rest of MEA